Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 192

1.

Secukinumab in multi-failure psoriatic patients: the last hope?

Magnano M, Loi C, Patrizi A, Sgubbi P, Balestri R, Rech G, Tasin L, Girardelli CR, Conti A, Odorici G, Campanati A, Offidani AM, Bardazzi F.

J Dermatolog Treat. 2018 Jan 15:1-9. doi: 10.1080/09546634.2018.1427206. [Epub ahead of print]

PMID:
29334270
2.

Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways.

Molinelli E, Campanati A, Ganzetti G, Brisigotti V, Offidani A.

Curr Pharm Biotechnol. 2018 Jan 3. doi: 10.2174/1389201019666180103140643. [Epub ahead of print]

PMID:
29299984
3.

In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Gram-positive cocci isolated from surgical wound infections.

Simonetti O, Morroni G, Ghiselli R, Orlando F, Brenciani A, Xhuvelaj L, Provinciali M, Offidani A, Guerrieri M, Giacometti A, Cirioni O.

J Med Microbiol. 2018 Jan;67(1):139-143. doi: 10.1099/jmm.0.000649. Epub 2017 Nov 20.

PMID:
29154746
4.

A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis.

Salaffi F, Di Carlo M, Luchetti MM, Di Donato E, Campanati A, Benfaremo D, Nicolini M, Carotti M, Giacchetti A, Ganzetti G, Bugatti L, Gabrielli A, Offidani AM.

Clin Exp Rheumatol. 2017 Nov 16. [Epub ahead of print]

PMID:
29148421
5.

Correlation between immunohistochemical staining of CEACAM1 and clinicopathological findings in oral pre-neoplastic lesions and squamous cell carcinoma.

Simonetti O, Lucarini G, Rubini C, Zizzi A, Aspriello SD, Di Primio R, Offidani AM.

Med Mol Morphol. 2017 Sep 8. doi: 10.1007/s00795-017-0169-4. [Epub ahead of print]

PMID:
28887602
6.

Effectiveness of etanercept in children with plaque psoriasis in real practice: a one-year multicenter retrospective study.

Di Lernia V, Guarneri C, Stingeni L, Gisondi P, Bonamonte D, Calzavara Pinton PG, Offidani A, Hansel K, Girolomoni G, Filoni A, Belloni Fortina A, Ficarelli E, Cannavò SP.

J Dermatolog Treat. 2017 Aug 18:1-3. doi: 10.1080/09546634.2017.1364692. [Epub ahead of print]

PMID:
28783991
7.

Role of Daptomycin on Burn Wound Healing in an Animal Methicillin-Resistant Staphylococcus aureus Infection Model.

Simonetti O, Lucarini G, Orlando F, Pierpaoli E, Ghiselli R, Provinciali M, Castelli P, Guerrieri M, Di Primio R, Offidani A, Giacometti A, Cirioni O.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00606-17. doi: 10.1128/AAC.00606-17. Print 2017 Sep.

PMID:
28696234
8.

Botulinum Toxin Off-Label Use in Dermatology: A Review.

Campanati A, Martina E, Giuliodori K, Consales V, Bobyr I, Offidani A.

Skin Appendage Disord. 2017 Mar;3(1):39-56. doi: 10.1159/000452341. Epub 2017 Feb 1. Review.

9.

Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox?

Martina E, Campanati A, Giuliodori K, Offidani A.

Acta Dermatovenerol Alp Pannonica Adriat. 2017 Mar;26(1):21-23.

10.

Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis.

Gisondi P, Altomare G, Ayala F, Bardazzi F, Bianchi L, Chiricozzi A, Costanzo A, Conti A, Dapavo P, De Simone C, Foti C, Naldi L, Offidani A, Parodi A, Piaserico S, Prignano F, Rongioletti F, Stingeni L, Talamonti M, Girolomoni G.

J Eur Acad Dermatol Venereol. 2017 May;31(5):774-790. doi: 10.1111/jdv.14114. Epub 2017 Feb 27.

PMID:
28244153
11.

Certolizumab pegol for the treatment of psoriasis.

Campanati A, Benfaremo D, Luchetti MM, Ganzetti G, Gabrielli A, Offidani A.

Expert Opin Biol Ther. 2017 Mar;17(3):387-394. doi: 10.1080/14712598.2017.1283401. Epub 2017 Feb 6. Review.

PMID:
28165828
12.

Photoprotection and photodermatitis: a case.

Martina E, Rosa L, Postacchini V, Simonetti O, Cataldi I, Offidani A.

Contact Dermatitis. 2017 Jan;76(1):54-55. doi: 10.1111/cod.12644. No abstract available.

PMID:
27957757
13.

Switching from a biological therapy to another biologic agent in psoriatic patients: the experience of PsOMarche group.

Ganzetti G, Campanati A, Bettacchi A, Brandozzi G, Brisigotti V, Bugatti L, Cataldi I, Filosa G, Giacchetti A, Lemme G, Morresi L, Nicolini M, Postacchini V, Ricotti G, Rosa L, Simonacci M, Offidani A.

G Ital Dermatol Venereol. 2018 Feb;153(1):5-10. doi: 10.23736/S0392-0488.16.05463-8. Epub 2016 Nov 15.

PMID:
27845513
14.

Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis.

Cirioni O, Simonetti O, Pierpaoli E, Barucca A, Ghiselli R, Orlando F, Pelloni M, Trombettoni MM, Guerrieri M, Offidani A, Giacometti A, Provinciali M.

Diagn Microbiol Infect Dis. 2016 Dec;86(4):392-398. doi: 10.1016/j.diagmicrobio.2016.09.010. Epub 2016 Sep 17.

PMID:
27712928
15.

TNF-α inhibitors reduce the pathological Th1 -Th17 /Th2 imbalance in cutaneous mesenchymal stem cells of psoriasis patients.

Campanati A, Orciani M, Lazzarini R, Ganzetti G, Consales V, Sorgentoni G, Di Primio R, Offidani A.

Exp Dermatol. 2017 Apr;26(4):319-324. doi: 10.1111/exd.13139. Epub 2016 Oct 24.

PMID:
27376466
16.

Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis.

Ganzetti G, Campanati A, Santarelli A, Sartini D, Molinelli E, Brisigotti V, Di Ruscio G, Bobyr I, Emanuelli M, Offidani A.

J Int Med Res. 2016 Sep;44(1 suppl):10-14.

17.

The effect of etanercept on vascular endothelial growth factor production by cutaneous mesenchymal stem cells from patients with psoriasis.

Campanati A, Orciani M, Ganzetti G, Consales V, Di Primio R, Offidani A.

J Int Med Res. 2016 Sep;44(1 suppl):6-9.

18.

T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: at the origin of the problem.

Orciani M, Campanati A, Caffarini M, Ganzetti G, Consales V, Lucarini G, Offidani A, Di Primio R.

Br J Dermatol. 2017 Jun;176(6):1569-1576. doi: 10.1111/bjd.15078. Epub 2017 Apr 27.

PMID:
27639070
19.

The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study.

Campanati A, Molinelli E, Ganzetti G, Giuliodori K, Minetti I, Taus M, Catani M, Martina E, Conocchiari L, Offidani A.

J Dermatolog Treat. 2017 May;28(3):206-212. doi: 10.1080/09546634.2016.1214666. Epub 2016 Aug 23.

PMID:
27552000
20.

Efficacy and Safety of Topical Pidobenzone 4% as Adjuvant Treatment for Solar Lentigines: Result of a Randomized, Controlled, Clinical Trial.

Campanati A, Giannoni M, Scalise A, De Blasio S, Giuliano A, Giuliodori K, Ganzetti G, Bolletta E, Di Benedetto G, Offidani A.

Dermatology. 2016;232(4):478-83. doi: 10.1159/000447356. Epub 2016 Aug 12.

Supplemental Content

Loading ...
Support Center